Join
Live feed
·
INSIDERFilingvia Quantisnow
Recursion Pharmaceuticals Inc. logo

Director Gibson Christopher converted options into 20,000 shares and gifted 20,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RXRX (Recursion Pharmaceuticals Inc.) and more on Quantisnow.